Director, President & CEO · FILANA THERAPEUTICS, INC. · Common Stock
Side
BUY
Value
$78K
Shares
93.1K
Price
$0.84
Executed
Sep 28, 2026
Disclosed
Sep 30, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 28 executedSep 30, 2026 disclosed
FLNA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · FLNA
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Barry Richard filed this Form 4 reporting a open-market purchase of FLNA on Sep 28, 2026. It became public on Sep 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President & CEO
Barry Richardcik:0001562371
Issuer
FILANA THERAPEUTICS, INC.cik:0001069530
Revision history · 0
No field has changed since this record was first ingested.
